Samil Pharm (000520) — Cash Flow Quality Index
Latest as of June 2024:
5.01x
Samil Pharm (000520) has a Cash Flow Quality Index of 5.01x as of June 2024. Operating cash flow of ₩1.75 Billion exceeds net income of ₩350.31 Million, indicating high earnings quality where cash backs reported profits. Explore debt repayment capacity of Samil Pharm to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
5.01x
Operating CF / Net Income
Operating Cash Flow
₩1.75 Billion
KRW
Net Income
₩350.31 Million
KRW
Data as of
Jun 2024
Most recent filing
Samil Pharm Cash Flow Quality Index (2013–2023)
Historical Cash Flow Quality Index for Samil Pharm across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Samil Pharm (000520) cash flow conversion.
Annual Cash Flow Quality Index for Samil Pharm (2013–2023)
Year-by-year earnings quality comparison for Samil Pharm.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 7.06x | ₩11.75 Billion | ₩1.66 Billion | ▲ +21.7% |
| 2020 | 5.80x | ₩7.77 Billion | ₩1.34 Billion | ▼ -56.9% |
| 2019 | 13.47x | ₩10.59 Billion | ₩786.26 Million | ▲ +111.9% |
| 2016 | 6.35x | ₩5.63 Billion | ₩886.60 Million | ▲ +28.1% |
| 2015 | 4.96x | ₩2.92 Billion | ₩588.37 Million | ▲ +1086.3% |
| 2013 | -0.50x | ₩-3.99 Billion | ₩7.93 Billion | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.